子宫内膜异位症:基于O-RADS的评估与恶变风险
本文综述子宫内膜异位症的影像表现,重点讨论子宫内膜瘤在O-RADS系统中的风险分层、恶变影像特征及监测策略。O-RADS指南要求对子宫内膜瘤随访至2年,并根据临床因素决定后续随访;深部子宫内膜异位症尚无恶性肿瘤角度的影像监测共识。文章还探讨了子宫内膜异位症患者卵巢癌风险升高的新数据,并指出文献空白。
要点
- O-RADS依据超声或MR形态对附件病变进行风险分层,涵盖典型良性至不典型及恶变表现。
- O-RADS指南要求子宫内膜瘤随访至2年,后续随访依据临床因素决定。
- 深部子宫内膜异位症尚无恶性肿瘤角度的影像监测共识指南。
核心结论
- 综述探讨子宫内膜瘤影像表现、恶变影像特征、监测策略及文献空白,旨在更好理解恶变风险并鼓励对子宫内膜异位症患者进行长期影像监测的进一步研究。
研究设计与样本
- 综述;检索范围与纳入文献原文未报告。
关键影像表现/征象
- 子宫内膜瘤的影像表现及恶变时的影像特征为综述内容,原文未给出具体征象描述。
诊断标准与关键数值
- O-RADS依据超声或MR所见的影像形态对病变进行风险分层,从典型良性病变到不典型表现及恶变。
- O-RADS指南要求对子宫内膜瘤随访至2年,后续随访依据临床因素决定。
- rASRM分类、#ENZIAN分类和深部盆腔子宫内膜异位症指数(dPEI)用于评估疾病总体范围并辅助术前规划。
临床应用与阅片要点
- SRU共识小组推荐提供常规盆腔影像初次检出子宫内膜异位症的信息。
- O-RADS指南要求对子宫内膜瘤随访至2年,后续随访依据临床因素决定。
- 深部子宫内膜异位症尚无恶性肿瘤角度的影像监测共识指南。
局限性
- 深部子宫内膜异位症尚无恶性肿瘤角度的影像监测共识指南。
- 原文指出当前文献存在空白,并鼓励进一步研究以进行子宫内膜异位症患者的长期影像监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Endometriosis is a common disease, affecting approximately 10% of women of reproductive age. Several intersecting guidelines and consensus statements provide information on imaging diagnosis and surveillance strategies for endometriomas. SRU consensus panel recommendations provide information on initial detection of endometriosis on routine pelvic imaging. Revised American Society of Reproductive Medicine (rASRM) classification, the #ENZIAN classification, and the deep pelvic endometriosis index (dPEI) aim to assess the overall extent of disease and assist in presurgical planning. The Ovarian-Adnexal Reporting and Data System (O-RADS) aims to risk stratify lesions evaluated with US or MR based on their imaging morphology, from typical benign lesions to atypical presentations and malignant transformation. Emerging data shows increased risk of ovarian cancer in patients with endometriosis, especially following menopause and in those patients with long standing endometriosis. (Chen et al. in Front Oncol. 14:1329133, 2024;Streuli et al. in Climacteric. 20:138-143, 2017;Secosan et al. in Diagnostics (Basel). 10:134, 2020;Inceboz in Womens Health (Lond Engl). 11:711-715, 2015;Cassani et al. in Maturitas. 190, 2024;Gemmell et al. in Hum Reprod Update. 23:481-500, 2017;Giannella et al. in Cancers (Basel). 13:4026, 2021;) Current O-RADS guidelines mandate follow-up of endometriomas up to 2 years with further follow-up based on clinical factors. No consensus guidelines exist for imaging surveillance of patients with deep endometriosis from a malignancy standpoint. This review explores the imaging appearance of endometriomas, imaging features of malignant transformation, surveillance strategies and gaps in current literature, and attempts to better understand the risk of malignancy and to encourage further research for long-term imaging surveillance of endometriosis patients.
引用
- Suarez-Weiss KE, Patel-Lippmann K, Phillips C, et al. Endometriosis: assessment on O-RADS and risk of malignant transformation. Abdom Radiol (NY). 2025. PMID: 40137947. doi:10.1007/s00261-025-04885-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。